ID

28335

Beschrijving

NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz

Trefwoorden

Versies (2)
  1. 30-11-17 30-11-17 -
  2. 04-01-18 04-01-18 -
Houder van rechten

Prof. Dr. med. Georg Heß

Geüploaded op

4 januari 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Screening Exclusion criteria GOAL Trial B-cell Lymphoma NCT02499003

Engels

Screening Exclusion criteria GOAL Trial B-cell Lymphoma NCT02499003

1 Formulieren  
Admininstrative data
Beschrijving

Admininstrative data

Alias
UMLS CUI-1
C1320722
Subject ID
Beschrijving

Subject ID

Datatype

text

Alias
UMLS CUI [1]
C2348585
Exclusion criteria
Beschrijving

Exclusion criteria

Alias
UMLS CUI-1
C0680251
1. Lymphoma other than DLBCL, FL IIIB, transfomed indolent NHL
Beschrijving

Lymphoma other

Datatype

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0205394
2. CNS involvement (brain MRI is required only in cases of clinically suspicious involvement)
Beschrijving

CNS involvement

Datatype

boolean

Alias
UMLS CUI [1]
C0449389
3. Pregnant or breastfeeding women
Beschrijving

Pregnancy

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
4. Severe concomitant disease
Beschrijving

e.g. uncontrolled arterial hypertension, heart failure (NYHA III-IV), uncontrolled diabetes mellitus, pulmonary fibrosis, uncontrolled hyperlipoproteinaemia

Datatype

boolean

Alias
UMLS CUI [1,1]
C0243087
UMLS CUI [1,2]
C0205082
5. Myocardial infarction within the last 6 months
Beschrijving

Myocardial infarction

Datatype

boolean

Alias
UMLS CUI [1]
C0027051
6. Active uncontrolled infections incl. HIV-positivity, active Hepatitis B or C
Beschrijving

Hepatitis B Hepatitis C HIV-positive

Datatype

boolean

Alias
UMLS CUI [1,1]
C0019163
UMLS CUI [1,2]
C0019196
UMLS CUI [1,3]
C0019682
7. Vaccination with live vaccine within last 4 weeks
Beschrijving

Vaccination

Datatype

boolean

Alias
UMLS CUI [1]
C0042196
8. Mental status precluding patient's compliance
Beschrijving

Mental status compliance

Datatype

boolean

Alias
UMLS CUI [1,1]
C0278060
UMLS CUI [1,2]
C1321605
9. Known CD20 negativity
Beschrijving

CD20 negativity

Datatype

boolean

Alias
UMLS CUI [1,1]
C0054946
UMLS CUI [1,2]
C0205160
10. Diagnosed or treated for a malignancy other than NHL
Beschrijving

Except: adequately treated nonmelanoma skin cancer, curatively treated in-situ cancer of the Cervix, DCIS of the breast, or other solid tumors curatively treated with no evidence of disease for >3 years, or prostate cancer with a life expectancy of more than 2 years

Datatype

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0006826
11. Treatment with any approved anticancer agent within last 2 weeks
Beschrijving

Any agents must have been stoppped at least 2 weeks prior to day 1 of GOAL treatment and all treatment-related adverse events must have returned to Grade 1.

Datatype

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0003392
12. Prior exposition to Obinutuzumab or Pixantrone
Beschrijving

therapy Obinutuzumab Pixantrone

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C2742503
UMLS CUI [1,3]
C0253355
13. History of hypersensitivity to medicinal products with similar chemical structure as the trial medication
Beschrijving

Hypersensitivity Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
14. Active participation in other interventional clinical trials during the present clinical trial or within the last 2 weeks prior to treatment initiation
Beschrijving

Concurrent participation in non-treatment studies is not excluded.

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
15. Medical or psychological conditions that would jeopardize an adequate and orderly completion of the trial.
Beschrijving

Compliance behavior Limited (extensiveness) Comorbidity

Datatype

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
Terug naar het begin van de pagina

Similar models

Screening Exclusion criteria GOAL Trial B-cell Lymphoma NCT02499003

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Admininstrative data
C1320722 (UMLS CUI-1)
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Lymphoma other
Item
1. Lymphoma other than DLBCL, FL IIIB, transfomed indolent NHL
boolean
C0024299 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
CNS involvement
Item
2. CNS involvement (brain MRI is required only in cases of clinically suspicious involvement)
boolean
C0449389 (UMLS CUI [1])
Pregnancy
Item
3. Pregnant or breastfeeding women
boolean
C0032961 (UMLS CUI [1])
Severe concomitant disease
Item
4. Severe concomitant disease
boolean
C0243087 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Myocardial infarction
Item
5. Myocardial infarction within the last 6 months
boolean
C0027051 (UMLS CUI [1])
Hepatitis B Hepatitis C HIV-positive
Item
6. Active uncontrolled infections incl. HIV-positivity, active Hepatitis B or C
boolean
C0019163 (UMLS CUI [1,1])
C0019196 (UMLS CUI [1,2])
C0019682 (UMLS CUI [1,3])
Vaccination
Item
7. Vaccination with live vaccine within last 4 weeks
boolean
C0042196 (UMLS CUI [1])
Mental status compliance
Item
8. Mental status precluding patient's compliance
boolean
C0278060 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
CD20 negativity
Item
9. Known CD20 negativity
boolean
C0054946 (UMLS CUI [1,1])
C0205160 (UMLS CUI [1,2])
comorbidity Malignant Neoplasms
Item
10. Diagnosed or treated for a malignancy other than NHL
boolean
C0009488 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
Treatment anticancer agent
Item
11. Treatment with any approved anticancer agent within last 2 weeks
boolean
C0920425 (UMLS CUI [1,1])
C0003392 (UMLS CUI [1,2])
therapy Obinutuzumab Pixantrone
Item
12. Prior exposition to Obinutuzumab or Pixantrone
boolean
C0087111 (UMLS CUI [1,1])
C2742503 (UMLS CUI [1,2])
C0253355 (UMLS CUI [1,3])
Hypersensitivity Investigational New Drugs
Item
13. History of hypersensitivity to medicinal products with similar chemical structure as the trial medication
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
study subject participation status
Item
14. Active participation in other interventional clinical trials during the present clinical trial or within the last 2 weeks prior to treatment initiation
boolean
C2348568 (UMLS CUI [1])
Compliance behavior Limited (extensiveness) Comorbidity
Item
15. Medical or psychological conditions that would jeopardize an adequate and orderly completion of the trial.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial